Jump to content

Phenelzine and sequestration in the body


Recommended Posts

Dear all,

I just registered and hope you guys can help me with your knowledge.

If anyone could help me with some part of this or give me an idea what I have to look at to understand this, it would be very much appreciated:

I'm interested in the drug phenelzine (Nardil).
There are now studies showing it's usefulness in traumatic brain injury, mitochondrial functional preservation and several other diseases/problems, which all seem related to it's ability to scavenge several radical molecules (aldehydes etc.)
This opens several questions to me:
1) Does it's reactivity also mean it will readily react with some proteins etc., just like the compounds it will react with for positive effects (as explained above)?
2) What will happen with these adducts (ie hydrazones). Will they be further metabolized and become radicals again so the positive effects are more in splitting up the radical load so the body is better able to handle it or will they mainly be discreted?
3) Related to this: The drug has a biological half-life (as stated in wikipedia) of 11.6 hours.
However, if it does indeed react and under the condition these adducts won't be degraded again to phenelzine (or another hydrazine): Will this influence it's half-life related to load of reactive molecules in the body?
4) Has the scavenger-property meaning in a "normal" therapeutic setting (chronic use as antidepressant / anti-anxiety drug, lower dosage)?
5) Last one needs some further explanation: The drug (and it's metabolite PEH) also reacts with Pyridoxal phosphate, which plays a role in side and therapeutic effects (the latter one through blockage of PLP-dependent enzymes). This
(http://www.sciencedirect.com/science/article/pii/0041008X60900077?via%3Dihub) older study has shown pyridoxine pretreatment to be protective against toxicity of a very high dose of phenelzine in mice, while pyridoxal enhanced the same. Phenelzine and pyridoxal (phosphate) form adducts and inhibit pyridoxal kinase, probably resulting in the toxicity if enough enzymes are inhibited (or through resulting inhibition of other processes).
What I know is: Pyridoxal kinase binds to PLP dependent enzymes to give them the needed co-factor. Is someone able explain to me how pyridoxine would block the inhibition from happening?

I hope everything is understandable, English isn't my first language.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.